Literature DB >> 21906011

Ex vivo differentiation of natural killer cells from human umbilical cord blood CD34+ progenitor cells.

Maria João Pinho1, Michael Punzel, Mário Sousa, Alberto Barros.   

Abstract

Natural Killer (NK)-cells are peripheral blood lymphocytes that represent an important arm of the innate immune system. NK-cells play a critical role in the immune surveillance against tumors and virally infected cells in a major histocompatibiliy complex (MHC)-unrestricted fashion. We have explored such capacities of NK-cells after differentiation from hematopoietic stem and progenitor cells derived from human umbilical cord blood. Several culture conditions have been established supporting proliferation and subsequent differentiation of these cells in terms of receptor expression and specific lysis depending on the growth conditions in the presence and absence of supportive stromal feeders. We show that acquisition of Killer Immunoglobulin Receptor (KIR) as well as NK Cytotoxicity Receptor expressions is independent of culture condition whereas absence of stromal feeders did not support acquisition of CD94/NKG2A expression. Such KIR-positive/NKG2A-negative cells generated under different culture conditions showed strong and specific cytolytic activity which could have impact on further immunotherapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21906011     DOI: 10.3109/15419061.2011.610911

Source DB:  PubMed          Journal:  Cell Commun Adhes        ISSN: 1543-5180


  7 in total

1.  OP9 Feeder Cells Are Superior to M2-10B4 Cells for the Generation of Mature and Functional Natural Killer Cells from Umbilical Cord Hematopoietic Progenitors.

Authors:  Lara Herrera; Juan Manuel Salcedo; Silvia Santos; Miguel Ángel Vesga; Francisco Borrego; Cristina Eguizabal
Journal:  Front Immunol       Date:  2017-06-30       Impact factor: 7.561

Review 2.  The role of natural killer cell in gastrointestinal cancer: killer or helper.

Authors:  Feixue Wang; Jennie Ka Ching Lau; Jun Yu
Journal:  Oncogene       Date:  2020-12-01       Impact factor: 9.867

3.  Overcoming the UCB HSCs -Derived NK cells Dysfunction through Harnessing RAS/MAPK, IGF-1R and TGF-β Signaling Pathways.

Authors:  Alireza Shokouhifar; Gholamreza Anani Sarab; Mahboubeh Yazdanifar; Mohammad Fereidouni; Masoumeh Nouri; Marzieh Ebrahimi
Journal:  Cancer Cell Int       Date:  2021-06-07       Impact factor: 5.722

Review 4.  Natural killer cells for cancer immunotherapy: pluripotent stem cells-derived NK cells as an immunotherapeutic perspective.

Authors:  Cristina Eguizabal; Olatz Zenarruzabeitia; Jorge Monge; Silvia Santos; Miguel Angel Vesga; Natalia Maruri; Arantza Arrieta; Marta Riñón; Estibaliz Tamayo-Orbegozo; Laura Amo; Susana Larrucea; Francisco Borrego
Journal:  Front Immunol       Date:  2014-09-15       Impact factor: 7.561

Review 5.  Selection and expansion of natural killer cells for NK cell-based immunotherapy.

Authors:  Petra S A Becker; Garnet Suck; Paulina Nowakowska; Evelyn Ullrich; Erhard Seifried; Peter Bader; Torsten Tonn; Christian Seidl
Journal:  Cancer Immunol Immunother       Date:  2016-01-25       Impact factor: 6.968

6.  A simple method for in vitro preparation of natural killer cells from cord blood.

Authors:  Yong Xu Mu; Yu Xia Zhao; Bing Yao Li; Hong Jing Bao; Hui Jiang; Xiao Lei Qi; Li Yun Bai; Yun Hong Wang; Zhi Jie Ma; Xiao Yun Wu
Journal:  BMC Biotechnol       Date:  2019-11-21       Impact factor: 2.563

7.  Adult peripheral blood and umbilical cord blood NK cells are good sources for effective CAR therapy against CD19 positive leukemic cells.

Authors:  L Herrera; S Santos; M A Vesga; J Anguita; I Martin-Ruiz; T Carrascosa; M Juan; C Eguizabal
Journal:  Sci Rep       Date:  2019-12-10       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.